Are You a Candidate?
GLP-1 medications have transformed weight loss — but they are not for everyone.
Who Is Typically a Candidate
- BMI of 30 or higher (obesity), OR
- BMI of 27 or higher (overweight) with at least one weight-related health condition
Who Should Be Cautious
- Personal or family history of medullary thyroid cancer
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- History of pancreatitis
- Pregnancy or planning to become pregnant
The only way to know for sure is a medical evaluation. Find a Abilene provider →
The short version
- GLP-1 candidates typically have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition.
- The article advises caution for anyone with a personal or family history of medullary thyroid cancer, a contraindication named in the prescribing criteria.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2) is listed as a second caution flag alongside that thyroid cancer history.
- A history of pancreatitis and pregnancy or planning to become pregnant are the other cautions named in the article.
- The article states the medications are not for everyone and the only way to know for sure is a medical evaluation.

Visual Guide

- A patient's blueprint for decoding clinical pathways, insurance step-therapy, and the true costs of treatment.

- Obesity rates have escalated rapidly, rising from 30.5% to 41.9% of the population. Clinical guidelines now treat this not as a behavioral failure, but as a complex, chronic medical condition requiring systematic intervention.
- Overweight is the precursor stage: excess fat is stored but has not yet caused significant health problems, and early detection here prevents progression.
- Obesity is a complex, chronic condition where excess fat actively drives severe health issues.
- The clinical target: sustained 5-15% weight loss is the medical threshold required to manage cardiometabolic health and prevent prediabetes progression.

- The Biological Barrier: Why Willpower Is Not Enough Dominant Energy Balance Model Carbohydrate-Insulin Model Calories In / Calories Out Hormonal Response Assumes a linear relationship where weight Focuses on calorie quality.
- High-glycemic loss requires only a caloric deficit.
- foods cause rapid insulin spikes.
- Fails to account for hormonal influences on Actively promotes lipogenesis (fat storage) appetite and metabolic adaptation.
- The Reality: Not all calories are processed equally.

- The Metabolic Set Point Feedback Loop The human body actively defends its weight through a biological feedback system.
- This evolutionary defense mechanism explains why early weight loss often Caloric Restriction plateaus, and why higher tiers of medical intervention are clinically necessary to break the cycle.

- The Step-Therapy Pathway: insurance approvals for weight management strictly follow established clinical guidelines, and navigating coverage requires completing each medical tier before advancing.
- Tier 1: Comprehensive Lifestyle Intervention (CLI) - the foundational baseline requirement.
- Tier 2: Anti-Obesity Medications - unlocked when biology resists lifestyle changes.
- Tier 3: Metabolic Bariatric Surgery - reserved for significant obesity-related conditions after other methods plateau.

- Tier 1: Comprehensive Lifestyle Intervention (CLI) CLI combines documented changes in behavioral habits, food intake, and physical activity with support The Medical Trigger Advantage from a health care team member.
- It is the mandatory prerequisite for all subsequent insurance Initiating CLl after a medical event (e.g., a coverage.
📄 Download the Medical Weight Loss Navigator (PDF)
Related Articles
Compare your options: Browse all comparison guides →
Want help finding the right medical weight loss provider? Tell us what you're looking for and we'll help you connect with Abilene providers who can help. Get matched with local providers → — no obligation. This is written for people around Abilene, TX who are looking into qualification for GLP-1 and want the honest version rather than a sales page.